Less than $10/month! Get more Watchlists, Portfolios, Custom Views and Chart Templates with Barchart Plus. FREE 30 Day Trial
or

Cleveland Biolabs (CBLI)

Cleveland Biolabs (CBLI)
N/A x N/A N/A x N/A
Post-market by (Cboe BZX)
3.17 -0.25 (-7.31%) 08/31/21 [NASDAQ]
N/A x N/A N/A x N/A
Post-market 3.17 unch (unch) -
Quote Overview for Tue, Aug 31st, 2021
Day Low
3.11
Day High
3.52
Open 3.44
Previous Close 3.42 3.42
Volume 116,400 116,400
Avg Vol 124,330 124,330
Stochastic %K 57.69% 57.69%
Weighted Alpha -0.71 -0.71
5-Day Change -0.28 (-8.12%) -0.28 (-8.12%)
52-Week Range 1.62 - 10.97 1.62 - 10.97
  • 1D
  • 5D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
  • MAX
Full Chart
  • OHLC Bars
  • Colored OHLC Bars
  • HLC Bars
  • Candlestick Hollow
  • Candlestick Open-to-Close
  • Candlestick Close-to-Close
  • Heikin-Ashi
  • Line Chart
  • Area Chart
  • Renko
  • Column
  • Baseline
  • Line Break
  • Range
  • Kagi
  • Point And Figure
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 49,068
  • Shares Outstanding, K 15,479
  • Annual Sales, $ 260 K
  • Annual Income, $ -2,400 K
  • EBIT $ N/A
  • EBITDA $ N/A
  • 60-Month Beta 0.70
  • Price/Sales 201.29
  • Price/Cash Flow N/A
  • Price/Book 3.62
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -0.04
  • Most Recent Earnings N/A on N/A
  • Next Earnings Date 08/16/21
  • Annual Dividend & Yield 0.00 (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Price Performance

See More
Period Period Low Period High Performance
1-Month
2.70 +17.41%
on 08/16/21
Period Open: 4.30
4.23 -25.06%
on 08/02/21
-1.13 (-26.28%)
since 07/30/21
3-Month
2.70 +17.41%
on 08/16/21
Period Open: 5.40
7.10 -55.35%
on 07/06/21
-2.23 (-41.30%)
since 05/28/21
52-Week
1.62 +95.68%
on 09/04/20
Period Open: 1.88
10.97 -71.11%
on 02/18/21
+1.29 (+68.62%)
since 08/28/20

Most Recent Stories

More News
Genome Protection Announces Publication of the Next Generation Deimmunized TLR5 Agonist, GP532

The substantially improved pharmacological profile of GP532 opens new opportunities for broader therapeutic applications of this class of pharmaceuticals BUFFALO, NY / ACCESSWIRE / April 14, 2021 / Genome...

CBLI : 3.17 (-7.31%)
Cleveland BioLabs, Inc. Announces Closing of $14 Million Registered Direct Offering of Common Stock

BUFFALO, NY / ACCESSWIRE / February 23, 2021 / Cleveland BioLabs, Inc. (NASDAQ:CBLI), today announced that it has closed its previously announced registered direct offering for the issuance and sale of...

CBLI : 3.17 (-7.31%)
Cleveland BioLabs, Inc. Announces $14 Million Registered Direct Offering of Common Stock

BUFFALO, NY / ACCESSWIRE / February 19, 2021 / Cleveland BioLabs, Inc. (NASDAQ:CBLI), today announced that it has entered into definitive agreements with certain healthcare-focused and institutional investors...

CBLI : 3.17 (-7.31%)
Cleveland BioLabs, Inc. Files Registration Statement on Form S-4 for Proposed Merger with Cytocom Inc.

Combined public entity to develop and commercialize next-generation immune therapies that address unmet needs in oncology, infectious disease, inflammation and auto-immune-mediated conditions FORT COLLINS,...

CBLI : 3.17 (-7.31%)
SHAREHOLDER ALERT: Rigrodsky Law, P.A. Reminds Investors of Investigations of CBLI, NEBC, THCB, and FTOC Mergers

WILMINGTON, Del., Feb. 16, 2021 (GLOBE NEWSWIRE) -- Rigrodsky Law, P.A. announces that it is investigating:

CBLI : 3.17 (-7.31%)
NEBC : 10.99 (+10.23%)
THCB : 10.00 (-1.96%)
FTOC : 10.76 (+2.38%)

Business Summary

Cytocom Inc. is a clinical-stage biopharmaceutical company. It involved in developing novel immunotherapies targeting autoimmune, inflammatory, infectious diseases and cancers based on a proprietary platform designed to rebalance the body's immune system and restore homeostasis. Cytocom Inc., formerly...

See More

Key Turning Points

3rd Resistance Point 3.83
2nd Resistance Point 3.68
1st Resistance Point 3.42
Last Price 3.17
1st Support Level 3.01
2nd Support Level 2.86
3rd Support Level 2.60

See More

52-Week High 10.97
Fibonacci 61.8% 7.40
Fibonacci 50% 6.30
Fibonacci 38.2% 5.19
Last Price 3.17
52-Week Low 1.62

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar

Trading Volume: The most powerful technical indicator in the world